Suppr超能文献

聚焦 COVID-19 与心血管疾病。

A close-up on COVID-19 and cardiovascular diseases.

机构信息

Cardiology Division in Geriatric Institute, Hebei General Hospital, Shijiazhuang, Hebei, China.

General Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

出版信息

Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1057-1060. doi: 10.1016/j.numecd.2020.04.001. Epub 2020 Apr 8.

Abstract

AIMS

To analyze the potential mechanism of cardiovascular dysfunctions induced by Coronavirus Disease 2019 (COVID-19) and to evaluate more effective therapeutic pathways for patients with cardiovascular diseases.

DATA SYNTHESIS

COVID-19 mainly invades the lungs, causing its serious damage. Studies found that COVID-19 induced the renin-angiotensin system imbalance, inflammatory storm, hypoxemia, stress response, and so on; all contributed to hypertension and serious myocardial damage in the process of virus pathogenesis, even increasing mortality in COVID-19 patients.

CONCLUSION

In the process of management of COVID-19 infections, close attention should be paid on both lung and cardiovascular damage, especially on those with only symptoms of cardiovascular diseases. Early identification, timely and effective treatments, and maintenance of hemodynamics and electrophysiological stability are of great significance on effective treatment and long-term prognosis.

摘要

目的

分析 2019 年冠状病毒病(COVID-19)引起的心血管功能障碍的潜在机制,并评估心血管疾病患者更有效的治疗途径。

数据综合

COVID-19 主要侵犯肺部,造成严重损害。研究发现,COVID-19 引起肾素-血管紧张素系统失衡、炎症风暴、低氧血症、应激反应等,这些都有助于病毒发病过程中的高血压和严重心肌损伤,甚至增加 COVID-19 患者的死亡率。

结论

在 COVID-19 感染的管理过程中,应密切关注肺部和心血管损伤,特别是那些仅有心血管疾病症状的患者。早期识别、及时有效的治疗以及维持血流动力学和电生理稳定性对有效治疗和长期预后具有重要意义。

相似文献

1
A close-up on COVID-19 and cardiovascular diseases.聚焦 COVID-19 与心血管疾病。
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1057-1060. doi: 10.1016/j.numecd.2020.04.001. Epub 2020 Apr 8.
2
Crucial Conversations With Patients in the Era of COVID-19.COVID-19时代与患者的关键对话
Circulation. 2020 Jul 21;142(3):191-193. doi: 10.1161/CIRCULATIONAHA.120.047374. Epub 2020 May 6.
5
SCAI initiatives during the COVID-19 pandemic.新冠疫情期间的SCAI倡议。
Catheter Cardiovasc Interv. 2020 Nov;96(5):995-996. doi: 10.1002/ccd.29058. Epub 2020 Jun 20.
6
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.心血管疾病可能导致 COVID-19 的进展和预后不良。
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1061-1067. doi: 10.1016/j.numecd.2020.04.013. Epub 2020 Apr 18.
7
Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective.《COVID-19 大流行对心血管的影响:全球视角》
Can J Cardiol. 2020 Jul;36(7):1068-1080. doi: 10.1016/j.cjca.2020.05.018. Epub 2020 May 16.
8
10
Coronavirus disease 2019 and cardiovascular implications.新型冠状病毒病 2019 与心血管影响。
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):725-732. doi: 10.2459/JCM.0000000000001068.

引用本文的文献

本文引用的文献

5
Coronavirus infections and immune responses.冠状病毒感染与免疫应答。
J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7.
6
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
7
The Middle East Respiratory Syndrome (MERS).中东呼吸综合征(MERS)。
Infect Dis Clin North Am. 2019 Dec;33(4):891-905. doi: 10.1016/j.idc.2019.08.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验